News

Q2 2025 Management View CEO Gail Koziara Boudreaux addressed the company's revised full year outlook, stating, "We know this ...
Q2 2025 Management View Jonas Prising, Chairman & CEO, opened the call stating that "employers facing not only macroeconomic ...
The Indianapolis company reduced its 2025 earnings target to $24.10 a share from a prior estimated range between $28.30 and $29 a share. On an adjusted basis, Elevance cut its projection to $30 a ...
Live Updates Live Coverage Updates appear automatically as they are published. Conference call starts at 11 AM Eastern 9:50 ...
Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...
S$1.88m (up from S$20.2m loss in FY 2024). Profit margin: 0.6% (up from net loss in FY 2024). EPS: S$0.001 (up from S$0.006 ...
Dorian's strong FCF and capital allocation shine, but risks like tariffs and competition pose challenges. See here for more ...
JPMorgan Chase posted second-quarter earnings of $5.24 per share, topping Wall Street’s expectations of $4.48. On an adjusted ...
Rolling EPS (earnings per share) gives an annual EPS estimate by combining EPS from the past two quarters with estimated EPS from the next two quarters.